102 related articles for article (PubMed ID: 21131317)
1. Large-cell lung carcinoma with basaloid architecture and neuroendocrine differentiation: a new type of combined large-cell neuroendocrine carcinoma.
Morbini P; Inghilleri S
Int J Surg Pathol; 2011 Apr; 19(2):252-8. PubMed ID: 21131317
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
3. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck.
Serrano MF; El-Mofty SK; Gnepp DR; Lewis JS
Hum Pathol; 2008 Apr; 39(4):591-8. PubMed ID: 18284937
[TBL] [Abstract][Full Text] [Related]
4. The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung.
Jiang SX; Kameya T; Shinada J; Yoshimura H
Mod Pathol; 1999 Apr; 12(4):362-9. PubMed ID: 10229500
[TBL] [Abstract][Full Text] [Related]
5. [p40 Negative Basaloid Squamous Cell Carcinoma of the Lung;Report of a Case].
Maki R; Sugita S; Ono Y; Miyajima M; Tada M; Takahashi Y; Mishina T; Watanabe A
Kyobu Geka; 2018 Jul; 71(7):547-550. PubMed ID: 30042259
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine differentiation distinguishes basaloid variant of lung squamous cell carcinoma.
Keyhanian K; Phillips WJ; Yeung BS; Gomes M; Lo B; Sekhon HS
Diagn Pathol; 2022 May; 17(1):46. PubMed ID: 35538551
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic issues with cytopathologic interpretation of lung neoplasms displaying high-grade basaloid or neuroendocrine morphology.
Maleki Z
Diagn Cytopathol; 2011 Mar; 39(3):159-67. PubMed ID: 21319315
[TBL] [Abstract][Full Text] [Related]
8. Cytological, histological, and immunohistochemical findings of pulmonary carcinomas with basaloid features.
Crapanzano JP; Loukeris K; Borczuk AC; Saqi A
Diagn Cytopathol; 2011 Feb; 39(2):92-100. PubMed ID: 21254456
[TBL] [Abstract][Full Text] [Related]
9. Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance.
Brambilla E; Moro D; Veale D; Brichon PY; Stoebner P; Paramelle B; Brambilla C
Hum Pathol; 1992 Sep; 23(9):993-1003. PubMed ID: 1381335
[TBL] [Abstract][Full Text] [Related]
10. Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung.
Sturm N; Lantuéjoul S; Laverrière MH; Papotti M; Brichon PY; Brambilla C; Brambilla E
Hum Pathol; 2001 Sep; 32(9):918-25. PubMed ID: 11567220
[TBL] [Abstract][Full Text] [Related]
11. Basaloid carcinoma of the lung associated with central cavitation: a unique surgical case focusing on cytological and immunohistochemical findings.
Yamada S; Noguchi H; Nabeshima A; Tasaki T; Kitada S; Baba T; Uramoto H; Hanagiri T; Sasaguri Y
Diagn Pathol; 2012 Dec; 7():175. PubMed ID: 23231806
[TBL] [Abstract][Full Text] [Related]
12. Multicentric basaloid carcinoma of lung clinically mimicking metastatic carcinoma: a case report.
Bhagavathi S; Chang CH
Int J Surg Pathol; 2009 Feb; 17(1):68-71. PubMed ID: 18480394
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine differentiation in non-small cell lung carcinomas.
Baldi A; Groger AM; Esposito V; Di Marino MP; Ferrara N; Baldi F
In Vivo; 2000; 14(1):109-14. PubMed ID: 10757067
[TBL] [Abstract][Full Text] [Related]
15. Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Bolon I; Devouassoux M; Robert C; Moro D; Brambilla C; Brambilla E
Am J Pathol; 1997 May; 150(5):1619-29. PubMed ID: 9137088
[TBL] [Abstract][Full Text] [Related]
16. Divergent differentiation in neuroendocrine lung tumors.
Brambilla E; Lantuejoul S; Sturm N
Semin Diagn Pathol; 2000 May; 17(2):138-48. PubMed ID: 10839614
[TBL] [Abstract][Full Text] [Related]
17. 34betaE12 Cytokeratin Immunodetection in the Differential Diagnosis of Small Cell Tumors of Lung.
Viberti L; Bongiovanni M; Croce S; Bussolati G
Int J Surg Pathol; 2000 Oct; 8(4):317-322. PubMed ID: 11494008
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine carcinomas of the breast.
Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
[TBL] [Abstract][Full Text] [Related]
19. Insights into the achaete-scute homolog-1 gene (hASH1) in normal and neoplastic human lung.
Miki M; Ball DW; Linnoila RI
Lung Cancer; 2012 Jan; 75(1):58-65. PubMed ID: 21684625
[TBL] [Abstract][Full Text] [Related]
20. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
Swarts DR; Ramaekers FC; Speel EJ
Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
